Literature DB >> 27439437

Proteome Dynamics Reveals Pro-Inflammatory Remodeling of Plasma Proteome in a Mouse Model of NAFLD.

Ling Li, Gurkan Bebek1, Stephen F Previs2, Jonathan D Smith, Rovshan G Sadygov3, Arthur J McCullough, Belinda Willard, Takhar Kasumov.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of cardiovascular disease. Because the liver is the major source of circulatory proteins, it is not surprising that hepatic disease could lead to alterations in the plasma proteome, which are therein implicated in atherosclerosis. The current study used low-density lipoprotein receptor-deficient (LDLR(-/-)) mice to examine the impact of Western diet (WD)-induced NAFLD on plasma proteome homeostasis. Using a (2)H2O-metabolic labeling method, we found that a WD led to a proinflammatory distribution of circulatory proteins analyzed in apoB-depleted plasma, which was attributed to an increased production. The fractional turnover rates of short-lived proteins that are implicated in stress-response, lipid metabolism, and transport functions were significantly increased with WD (P < 0.05). Pathway analyses revealed that alterations in plasma proteome dynamics were related to the suppression of hepatic PPARα, which was confirmed based on reduced gene and protein expression of PPARα in mice fed a WD. These changes were associated with ∼4-fold increase (P < 0.0001) in the proinflammatory property of apoB-depleted plasma. In conclusion, the proteome dynamics method reveals proinflammatory remodeling of the plasma proteome relevant to liver disease. The approach used herein may provide a useful metric of in vivo liver function and better enable studies of novel therapies surrounding NAFLD and other diseases.

Entities:  

Keywords:  HDL; NAFLD; atherosclerosis; heavy water; proteome dynamics

Mesh:

Substances:

Year:  2016        PMID: 27439437      PMCID: PMC5310220          DOI: 10.1021/acs.jproteome.6b00601

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  59 in total

1.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

2.  A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease.

Authors:  Zobair M Younossi; Ancha Baranova; Katharine Ziegler; Luca Del Giacco; Karen Schlauch; Timothy L Born; Hazem Elariny; Francesco Gorreta; Amy VanMeter; Abraham Younoszai; Janus P Ong; Zachary Goodman; Vikas Chandhoke
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

Review 3.  Phosphorylation of PPARs: from molecular characterization to physiological relevance.

Authors:  Claire Diradourian; Jean Girard; Jean-Paul Pégorier
Journal:  Biochimie       Date:  2005-01       Impact factor: 4.079

4.  Identification of protein coding regions by database similarity search.

Authors:  W Gish; D J States
Journal:  Nat Genet       Date:  1993-03       Impact factor: 38.330

Review 5.  Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence.

Authors:  Alberto Zambon; Philippe Gervois; Paolo Pauletto; Jean-Charles Fruchart; Bart Staels
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-01-19       Impact factor: 8.311

6.  SUMOylation of human peroxisome proliferator-activated receptor alpha inhibits its trans-activity through the recruitment of the nuclear corepressor NCoR.

Authors:  Benoit Pourcet; Inés Pineda-Torra; Bruno Derudas; Bart Staels; Corine Glineur
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

7.  Solubilization of low-density lipoprotein with sodium deoxycholate and recombination of apoprotein B with dimyristoylphosphatidylcholine.

Authors:  M T Walsh; D Atkinson
Journal:  Biochemistry       Date:  1983-06-21       Impact factor: 3.162

8.  Activation of the complement system in human nonalcoholic fatty liver disease.

Authors:  Sander S Rensen; Yanti Slaats; Ann Driessen; Carine J Peutz-Kootstra; Jeroen Nijhuis; Rudi Steffensen; Jan Willem Greve; Wim A Buurman
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

Review 9.  PPARalpha in atherosclerosis and inflammation.

Authors:  Fokko Zandbergen; Jorge Plutzky
Journal:  Biochim Biophys Acta       Date:  2007-05-21

10.  Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics.

Authors:  Graziella E Ronsein; Nathalie Pamir; Priska D von Haller; Daniel S Kim; Michael N Oda; Gail P Jarvik; Tomas Vaisar; Jay W Heinecke
Journal:  J Proteomics       Date:  2014-10-31       Impact factor: 4.044

View more
  9 in total

1.  Hepatic Mitochondrial Defects in a Nonalcoholic Fatty Liver Disease Mouse Model Are Associated with Increased Degradation of Oxidative Phosphorylation Subunits.

Authors:  Kwangwon Lee; Andrew Haddad; Abdullah Osme; Chunki Kim; Ahmad Borzou; Sergei Ilchenko; Daniela Allende; Srinivasan Dasarathy; Arthur McCullough; Rovshan G Sadygov; Takhar Kasumov
Journal:  Mol Cell Proteomics       Date:  2018-08-31       Impact factor: 5.911

2.  Glycation Reduces the Stability of ApoAI and Increases HDL Dysfunction in Diet-Controlled Type 2 Diabetes.

Authors:  Sangeeta R Kashyap; Abdullah Osme; Serguei Ilchenko; Makan Golizeh; Kwangwon Lee; Shuhui Wang; James Bena; Stephen F Previs; Jonathan D Smith; Takhar Kasumov
Journal:  J Clin Endocrinol Metab       Date:  2018-02-01       Impact factor: 5.958

3.  Increased serotransferrin and ceruloplasmin turnover in diet-controlled patients with type 2 diabetes.

Authors:  Makan Golizeh; Kwangwon Lee; Serguei Ilchenko; Abdullah Ösme; James Bena; Rovshan G Sadygov; Sangeeta R Kashyap; Takhar Kasumov
Journal:  Free Radic Biol Med       Date:  2017-10-25       Impact factor: 7.376

4.  HDL flux is higher in patients with nonalcoholic fatty liver disease.

Authors:  Arthur McCullough; Stephen F Previs; Jaividhya Dasarathy; Kwangwon Lee; Abdullah Osme; Chunki Kim; Serguei Ilchenko; Shuhui W Lorkowski; Jonathan D Smith; Srinivasan Dasarathy; Takhar Kasumov
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-09-10       Impact factor: 4.310

5.  Membrane organization of photosystem I complexes in the most abundant phototroph on Earth.

Authors:  C MacGregor-Chatwin; P J Jackson; M Sener; J W Chidgey; A Hitchcock; P Qian; G E Mayneord; M P Johnson; Z Luthey-Schulten; M J Dickman; D J Scanlan; C N Hunter
Journal:  Nat Plants       Date:  2019-07-22       Impact factor: 15.793

6.  Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism.

Authors:  Songsong Wang; Feiya Sheng; Liang Zou; Jianbo Xiao; Peng Li
Journal:  J Adv Res       Date:  2021-06-08       Impact factor: 10.479

7.  Temporal Dynamics of High-Density Lipoprotein Proteome in Diet-Controlled Subjects with Type 2 Diabetes.

Authors:  Karim G Kheniser; Abdullah Osme; Chunki Kim; Serguei Ilchenko; Takhar Kasumov; Sangeeta R Kashyap
Journal:  Biomolecules       Date:  2020-03-30

8.  Early Pro-Inflammatory Remodeling of HDL Proteome in a Model of Diet-Induced Obesity: 2H2O-Metabolic Labeling-Based Kinetic Approach.

Authors:  Prabodh Sadana; Li Lin; Mirjavid Aghayev; Serguei Ilchenko; Takhar Kasumov
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

9.  High-Resolution Mass Spectrometry for In Vivo Proteome Dynamics using Heavy Water Metabolic Labeling.

Authors:  Rovshan G Sadygov
Journal:  Int J Mol Sci       Date:  2020-10-22       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.